Lack of pharmacokinetic interaction between gemifloxacin and digoxin in healthy elderly volunteers

Chemotherapy

Volumn 45, Issue 6, 1999, Pages 485-490

  Vousden, Marika ^a,c   Allen, Ann ^a   Lewis, Anastasia ^a   Ehren, Norbert ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b Focus Clinical Drug Development GmbH   (Germany)

^c Clinical Pharmacology Statistics   (United Kingdom)

Author keywords

Digoxin; Drug interaction; Fluoroquinolone; Gemifloxacin; Pharmacokinetics

Indexed keywords

DIGOXIN; GEMIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DIGOXIN BLOOD LEVEL; DOUBLE BLIND PROCEDURE; DRUG CLEARANCE; DRUG TOLERABILITY; DRUG URINE LEVEL; ELECTROCARDIOGRAM; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; KIDNEY CLEARANCE; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; RASH; SIDE EFFECT; STEADY STATE;

AGED; ANTI-INFECTIVE AGENTS; CROSS-OVER STUDIES; DIGOXIN; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; MIDDLE AGED; NAPHTHYRIDINES;

EID: 0032737922     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007242     Document Type: Article

References (8)

1. Critchley IA, Broskey J, Coleman K: SB-265805 (LB20304a): In vitro activity, intracellular accumulation and killing of Legionella pneumophila in human macrophages. 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1998, San Diego, CA, USA. Poster F-100.
2. Smirnov A, Wellmer A, Gerber J, Maier K, Henne S, Nau R: Gemifloxacin is effective in experimental pneumococcal meningitis. 10th European Congress of Clinical Microbiology and Infectious Diseases, 1999, Berlin, Germany. Poster 223.
3. Allen A, Bygate E, Teillol-Foo M, Oliver S, Johnson M, Ward C: Pharmacokinetics and tolerability of gemifloxacin after administration of single oral doses to healthy volunteers; in: Abstracts from the 21st International Congress of Chemotherapy, Birmingham, UK. J Antimicrob Chemother 1999;44(suppl A): 137:Poster 440.
4. Allen A, Bygate E, Teillol-Foo M, Oliver S, Johnson M, Ward C: Multiple-dose pharmacokinetics and tolerability of gemifloxacin following oral doses to healthy volunteers; in: Abstracts from the 21st International Congress of Chemotherapy, Birmingham, UK. J Antimicrob Chemother 1999;44(suppl A):133:Poster 418.
5. Hager WD, Fenster P, Mayersohn M, Perrier D, Graves P, Marcus FI, Goldman S: Digoxin-quinidine interaction. Pharmacokinetic evaluation. N Engl J Med 1979;300:1238-1241.
6. Lisalo E: Clinical pharmacokinetics of digoxin. Clin Pharmacokinet 1977;2:1-16.
7. Hauschke D, Steinijans VW, Dilettie E: A distribution-free procedure for the statistical analysis of bioequivalence studies. Int J Clin Pharmacol Ther Tox 1990;28:72-78.
8. Jortani SA, Valdes R Jr: Digoxin and its related endogenous factors. Crit Rev Clin Lab Sci 1997;34:225-274.